Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods
Ellen F Eaton,1 Chastity McDavid,1 Mary Katy Banasiewicz,1 Michael J Mugavero,1 Sara J Knight2 1Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 2Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmi...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-09-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/patient-preferences-for-antiretroviral-therapy-effectiveness-quality-o-peer-reviewed-article-PPA |
id |
doaj-f141d7dbf12a49c99d3b5114a23e38e6 |
---|---|
record_format |
Article |
spelling |
doaj-f141d7dbf12a49c99d3b5114a23e38e62020-11-24T20:54:56ZengDove Medical PressPatient Preference and Adherence1177-889X2017-09-01Volume 111585159034763Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methodsEaton EFMcDavid CBanasiewicz MKMugavero MJKnight SJEllen F Eaton,1 Chastity McDavid,1 Mary Katy Banasiewicz,1 Michael J Mugavero,1 Sara J Knight2 1Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 2Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA Objective: The objective of this study was to understand patient preferences for contemporary antiretroviral therapy (ART) by focusing on three areas that have been understudied: minority patients (racial/ethnic and sexual minorities), experience with novel single-tablet regimens made available in the last 10 years, and patient concerns related to ART. The rationale was that identifying ART characteristics that are most desirable could inform provider prescribing practices, increase the use of patient-centered ART, maximize durability and ART adherence, and ultimately improve HIV outcomes, such as viral suppression and AIDS-related comorbidities.Methods: We recruited English- and Spanish-speaking persons living with HIV (PLWH) who were ≥19 years of age or older and had initiated ART after January 1, 2006, until saturation was reached (n=28). We excluded patients who had started on ART more than 10 years earlier, in order to ensure responses were relevant to more contemporary ART regimens. We recruited racial/ethnic and sexual minorities, including men who have sex with men and transgender participants, to reflect the current HIV epidemic. Nominal group technique was used to identify and prioritize preferences and concerns. Multi-voting analysis was used to quantify responses from most important (5 points) to least important (1 point).Results: For 28 diverse participants, clinical outcomes (162 points) and quality of life (120 points) were preferred. Hispanic participants were more concerned about accessibility than non-Hispanic (3.8 vs 1.9 average points/participant).Discussion: HIV-infected persons prioritize access, clinical outcomes, and quality of life when considering contemporary ART treatment. Providers, insurers and policy makers should incorporate these preferences when making decisions about ART. Keywords: HIV, preferences, immigrant, Hispanic, access to care https://www.dovepress.com/patient-preferences-for-antiretroviral-therapy-effectiveness-quality-o-peer-reviewed-article-PPAHIVantiretroviral therapypreferencesquality of life |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eaton EF McDavid C Banasiewicz MK Mugavero MJ Knight SJ |
spellingShingle |
Eaton EF McDavid C Banasiewicz MK Mugavero MJ Knight SJ Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods Patient Preference and Adherence HIV antiretroviral therapy preferences quality of life |
author_facet |
Eaton EF McDavid C Banasiewicz MK Mugavero MJ Knight SJ |
author_sort |
Eaton EF |
title |
Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods |
title_short |
Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods |
title_full |
Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods |
title_fullStr |
Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods |
title_full_unstemmed |
Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods |
title_sort |
patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods |
publisher |
Dove Medical Press |
series |
Patient Preference and Adherence |
issn |
1177-889X |
publishDate |
2017-09-01 |
description |
Ellen F Eaton,1 Chastity McDavid,1 Mary Katy Banasiewicz,1 Michael J Mugavero,1 Sara J Knight2 1Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 2Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA Objective: The objective of this study was to understand patient preferences for contemporary antiretroviral therapy (ART) by focusing on three areas that have been understudied: minority patients (racial/ethnic and sexual minorities), experience with novel single-tablet regimens made available in the last 10 years, and patient concerns related to ART. The rationale was that identifying ART characteristics that are most desirable could inform provider prescribing practices, increase the use of patient-centered ART, maximize durability and ART adherence, and ultimately improve HIV outcomes, such as viral suppression and AIDS-related comorbidities.Methods: We recruited English- and Spanish-speaking persons living with HIV (PLWH) who were ≥19 years of age or older and had initiated ART after January 1, 2006, until saturation was reached (n=28). We excluded patients who had started on ART more than 10 years earlier, in order to ensure responses were relevant to more contemporary ART regimens. We recruited racial/ethnic and sexual minorities, including men who have sex with men and transgender participants, to reflect the current HIV epidemic. Nominal group technique was used to identify and prioritize preferences and concerns. Multi-voting analysis was used to quantify responses from most important (5 points) to least important (1 point).Results: For 28 diverse participants, clinical outcomes (162 points) and quality of life (120 points) were preferred. Hispanic participants were more concerned about accessibility than non-Hispanic (3.8 vs 1.9 average points/participant).Discussion: HIV-infected persons prioritize access, clinical outcomes, and quality of life when considering contemporary ART treatment. Providers, insurers and policy makers should incorporate these preferences when making decisions about ART. Keywords: HIV, preferences, immigrant, Hispanic, access to care |
topic |
HIV antiretroviral therapy preferences quality of life |
url |
https://www.dovepress.com/patient-preferences-for-antiretroviral-therapy-effectiveness-quality-o-peer-reviewed-article-PPA |
work_keys_str_mv |
AT eatonef patientpreferencesforantiretroviraltherapyeffectivenessqualityoflifeaccessandnoveldeliverymethods AT mcdavidc patientpreferencesforantiretroviraltherapyeffectivenessqualityoflifeaccessandnoveldeliverymethods AT banasiewiczmk patientpreferencesforantiretroviraltherapyeffectivenessqualityoflifeaccessandnoveldeliverymethods AT mugaveromj patientpreferencesforantiretroviraltherapyeffectivenessqualityoflifeaccessandnoveldeliverymethods AT knightsj patientpreferencesforantiretroviraltherapyeffectivenessqualityoflifeaccessandnoveldeliverymethods |
_version_ |
1716793258469752832 |